Study to Test Tecovirimat for the Treatment of | Clinical Research Studies Listing

Recruiting

18 years - 99 years

All

25 participants needed

1 Location

Brief description of study

The study is testing a drug called, Tecovirimat, which is being tested to see if it works to treat human Monkeypox virus infection and if the study drug is safe in people. Participants in the study will take the tablets twice every day for two weeks and be checked by study nurses and study doctors. Study includes at least 6 clinical visits. Study duration is 2 months.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Monkeypox Virus
Age: 18 years - 99 years
Gender: All

Updated on 04 Aug 2024. Study ID: 852078

Find a site

Your Information has been sent successfully.

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.

Would you like to be notified about other trials? Sign up for Patient Notification Services.

Send a message

Enter your contact details to connect with study team

Primary Contact

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Are you comfortable with the informed consent process?

Yes

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

Study to Test Tecovirimat for the Treatment of Human Monkeypox Virus Disease

Brief description of study

Eligibility of study

Find a site

Interested in the study